Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 67126 - 67150 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Rosiglitazone	Approved Investigational	LINGO4	339398	downregulated	rosiglitazone results in decreased expression of LINGO4 mRNA	1q21.3	A22609
Rosiglitazone	Approved Investigational	LIPC	3990	upregulated	rosiglitazone results in increased expression of LIPC mRNA	15q21.3	A24095
Rosiglitazone	Approved Investigational	LIPE	3991	upregulated	rosiglitazone results in increased expression of LIPE mRNA	19q13.2	A24095
Rosiglitazone	Approved Investigational	LIPG	9388	downregulated	rosiglitazone results in decreased expression of LIPG mRNA	18q21.1	A22609
Rosiglitazone	Approved Investigational	LPL	4023	upregulated	rosiglitazone results in increased expression of LPL mRNA	8p21.3	A24122 A24096 A24109 A24123
Rosiglitazone	Approved Investigational	LRP1	4035	upregulated	rosiglitazone results in increased expression of LRP1 mRNA	12q13.3	A24124
Rosiglitazone	Approved Investigational	LRP11	84918	downregulated	rosiglitazone results in decreased expression of LRP11 mRNA	6q25.1	A10216
Rosiglitazone	Approved Investigational	LRRC8A	56262	downregulated	rosiglitazone results in decreased expression of LRRC8A mRNA	9q34.11	A22609
Rosiglitazone	Approved Investigational	LTBR	4055	upregulated	rosiglitazone results in increased expression of LTBR mRNA	12p13	A24100
Rosiglitazone	Approved Investigational	LTN1	26046	downregulated	rosiglitazone results in decreased expression of LTN1 mRNA	21q21.3	A20427
Rosiglitazone	Approved Investigational	MAN1A2	10905	downregulated	rosiglitazone results in decreased expression of MAN1A2 mRNA	1p12	A20427
Rosiglitazone	Approved Investigational	MAN1C1	57134	downregulated	rosiglitazone results in decreased expression of MAN1C1 mRNA	1p36.11	A10216
Rosiglitazone	Approved Investigational	MAP3K6	9064	downregulated	rosiglitazone results in decreased expression of MAP3K6 mRNA	1p36.11	A10216
Rosiglitazone	Approved Investigational	MAP4K1	11184	downregulated	rosiglitazone results in decreased expression of MAP4K1 mRNA	19q13.1-q13.4	A10216
Rosiglitazone	Approved Investigational	MAPRE3	22924	upregulated	rosiglitazone results in increased expression of MAPRE3 mRNA	2p23.3	A22609
Rosiglitazone	Approved Investigational	MASP2	10747	downregulated	rosiglitazone results in decreased expression of MASP2 mRNA	1p36.22	A22609
Rosiglitazone	Approved Investigational	MATN2	4147	downregulated	rosiglitazone results in decreased expression of MATN2 mRNA	8q22.1-q22.2	A22609
Rosiglitazone	Approved Investigational	MBL2	4153	upregulated	rosiglitazone results in increased expression of MBL2 mRNA	10q21.1	A22609
Rosiglitazone	Approved Investigational	MDM2	4193	upregulated	rosiglitazone results in increased expression of MDM2 mRNA	12q15	A20427
Rosiglitazone	Approved Investigational	METRN	79006	downregulated	rosiglitazone results in decreased expression of METRN mRNA	16p13.3	A10216
Rosiglitazone	Approved Investigational	MFSD2A	84879	downregulated	rosiglitazone results in decreased expression of MFSD2A mRNA	1p34.2	A22609
Rosiglitazone	Approved Investigational	MGAT4C	25834	downregulated	rosiglitazone results in decreased expression of MGAT4C mRNA	12q21.31-q21.32	A10216
Rosiglitazone	Approved Investigational	MID1IP1	58526	downregulated	rosiglitazone results in decreased expression of MID1IP1 mRNA	Xp11.4	A22609
Rosiglitazone	Approved Investigational	MLKL	197259	upregulated	rosiglitazone results in increased expression of MLKL mRNA	16q22.3	A22609
Rosiglitazone	Approved Investigational	MMP9	4318	downregulated	rosiglitazone results in decreased expression of MMP9 mRNA	20q13.12	A24125

Displaying entries 67126 - 67150 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability